Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-03-07

Clinical Trial Update: Safety, Tolerability and Pharmacokinetics (PK) Evaluation of BZ371A, Topically Administered [Phase 1]

View source ↗

Summary

Phase 1 clinical trial assessing safety, tolerability, and pharmacokinetics of BZ371A applied topically for erectile dysfunction, including post-radical prostat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BZ371A

Snippet

Sponsor: Biozeus Biopharmaceutical S.A. | Conditions: Erectile Dysfunction Following Radical Prostatectomy, Erectile Dysfunction | Phase 1 | Status: COMPLETED | Results posted: 2025-03-07